Omeros | OMER - Capital De Préstamo





Capital De Préstamo Cambio Fecha
Adma Biologics USD 192.84M 745K 2026-06
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Cytokinetics USD 248.2M 993K 2026-06
Gilead Sciences USD 20.86B 1.27B 2026-03
Heron Therapeutics USD 140.64M 975K 2025-12
Immunic USD 0 0 2024-06
Insmed USD 543.51M 1.3M 2026-06
Knight Therapeutics CAD 57.78M 26.92M 2025-12
MacroGenics USD 68.71M 1.29M 2026-03
Omeros USD 403.72M 27.2M 2024-06
Pacira USD 363.12M 4.53M 2026-06
Pfizer USD 60.5B 70M 2026-06
Rockwell Medical USD 8.65M 89K 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12